Boston Scientific Gets FDA’s Nod For Watchman Heart Device

March 15, 2015 1:44 PM

13 0

Boston Scientific Corporation (NYSE:BSX) finally sees its decade long pursuit coming to an end, as its heart device has received the US Food and Drug Administration's (FDA) approval.

Boston Scientific’s heart device, the Watchman Left Atrial Appendage (LAA) Closure Device, is a small umbrella-shaped product that works by closing the LAA to capture clots. It prevents clots from moving to the brain, minimizing the risk of strokes and systemic embolism.

Read more

To category page